- Intuitive Surgical, Inc. ISRG reported second-quarter revenue growth of 4% year-over-year to $1.52 billion, +6% on a constant currency basis, missing the consensus of $1.56 billion.
- The gross margin contracted by 270 bps to 67.2%. Operating income declined by 22.2% Y/Y to $397.6 million, and margin contracted by 880 bps to 26.1%.
- Adjusted Gross margin was 69.2%, down 252 bps, and adjusted operating margin was 34.9%, down by 792 bps.
- Adjusted EPS was $1.14, below the consensus of $1.19.
- Worldwide da Vinci procedures grew ~14% Y/Y. The compound annual growth rate between 2Q19 and 2Q22 was ~16%.
- ISRG placed 279 da Vinci Surgical Systems, a decrease of 15% Y/Y.
- The Company repurchased $500 million of common stock in the quarter.
- ISRG ended the quarter with $8.18 billion in cash, cash equivalents, and investments.
- Outlook: "The impact of the COVID-19 pandemic on the Company's business has, and continues to, differ by geography and region. COVID-19 has had, and will likely continue to have, an adverse impact on the Company's procedure volumes," said CEO Gary Guthart.
- Price Action: ISRG shares are trading lower by 12.84% at $197.89 during the post-market session on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
